ARTONI, ANDREA
ARTONI, ANDREA
DIPARTIMENTO DI MEDICINA INTERNA (attivo dal 01/01/1998 al 27/04/2012)
Acquired thrombotic thrombocytopenic purpura and HIV infection: a case report and review of the literature
2026 S. Rao, A. Liparoti, J.A. Giannotta, A. Artoni, A. Muscatello, A. Bandera, F. Peyvandi
Sex Differences in Cancer-Associated Thrombosis
2026 A. Giachi, D. Santagata, A. Truma, A. Artoni, P. Bucciarelli, L. Valenti, C. Ay, R. Gualtierotti
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study.
2025 B. Fattizzo, A. Marchetti, A. Bosi, C. Gurnari, J. Giannotta, G. Pedone, E. Rossi, V. Carrai, A. Guido, F. Brioschi, M. Carpenedo, M. Crugnola, D. Caramazza, L. Leuzzi, M. Marchetti, G. Merati, S. Malato, F. Vianello, A. Patriarca, H. Awada, M. Bortolotti, M. Canzi, N. Bolli, M. Capecchi, F. Chen, A. Artoni, J. Maciejewski, W. Barcellini
Therapeutic plasma exchange-related complications in patients with immune-mediated thrombotic thrombocytopenic purpura: Complications of therapeutic plasma-exchange
2025 P. Agosti, I. Mancini, A. Artoni, C. Cardone, P. De Leo, C. Bichard, A. Truma, B. Ferrari, J.A. Giannotta, N.N. Fantini, M.C. Mocellin, D. Prati, F. Peyvandi
Immune-mediated thrombotic thrombocytopenic purpura as a model of systemic microvascular dysfunction: moving from an acute to a chronic disorder
2025 P. Agosti, E. Ingenito, A. Truma, A. Artoni, F. Peyvandi
Evaluation of different platelet-dependent von Willebrand factor activity assays to assess the in vivo inhibitory effect of caplacizumab on the von Willebrand factor–platelet interaction
2025 P. Colpani, L. Baronciani, I. Mancini, C. Novembrino, A. Lecchi, G. Cozzi, P. De Leo, M.B. Anzoletti, S. La Marca, M. Boscarino, M.T. Pagliari, A. Artoni, F. Peyvandi
The risk of cerebral vein thrombosis associated with different types of combined hormonal contraceptives: a case-control study
2025 M. Abbattista, A. Truma, I. Martinelli, F. Gianniello, S.M. Passamonti, M. Capecchi, A. Artoni, F. Peyvandi, P. Bucciarelli
Main features of ischemic stroke in patients with acute immune-mediated thrombotic thrombocytopenic purpura
2024 A. Truma, I. Mancini, P. Agosti, A. Artoni, J.A. Giannotta, B. Ferrari, P. De Leo, F. Peyvandi
Comparative Investigation of Thromboelastometry and Thrombin Generation for Patients Receiving Direct Oral Anticoagulants or Vitamin K Antagonists
2024 A. Tripodi, M. Capecchi, E. Scalambrino, M. Clerici, B. Scimeca, P. Agosti, P. Bucciarelli, A. Artoni, F. Peyvandi
Treatment of immune-mediated thrombotic thrombocytopenic purpura without plasma exchange
2024 M. Capecchi, G. Gazzola, P. Agosti, P. De Leo, I. Mancini, B. Ferrari, J.A. Giannotta, A. Artoni, F. Peyvandi
A case of lymphadenopathies with concomitant multiple acquired hemostasis disorders in an adult female patient
2024 A. Truma, A. Artoni, J.A. Giannotta, M. Caronni, F. Peyvandi
Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
2023 P. Agosti, P. De Leo, M. Capecchi, B. Ferrari, I. Mancini, S. Gattillo, S.M. Trisolini, E. Rinaldi, G.M. Podda, L. Prezioso, P. Salutari, L. Facchini, D. Caramazza, G. Tolomelli, A. Artoni, F. Peyvandi
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients
2023 M. Capecchi, P. De Leo, M. Abbattista, I. Mancini, P. Agosti, M. Biganzoli, C. Suffritti, B. Ferrari, A. Lecchi, S. La Marca, L. Padovan, E. Scalambrino, M. Clerici, A. Tripodi, A. Artoni, R. Gualtierotti, F. Peyvandi
Covid-19 vaccination in patients with immune-mediated thrombotic thrombocytopenic purpura: a single-referral center experience
2023 S.M. Trisolini, S. Capria, A. Artoni, I. Mancini, M. Biglietto, G. Gentile, F. Peyvandi, A.M. Testi
Intravenous immunoglobulins in autoimmune cytopenias: an old tool with an alternative dosing schedule
2023 J.A. Giannotta, M. Capecchi, B. Fattizzo, A. Artoni, W. Barcellini
Corrigendum to 'External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019'
2022 S. Hassan, C.L. Ramspek, B. Ferrari, M. van Diepen, R. Rossio, R. Knevel, V. la Mura, A. Artoni, I. Martinelli, A. Bandera, A. Nobili, A. Gori, F. Blasi, C. Canetta, N. Montano, F.R. Rosendaal, F. Peyvandi
External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019
2022 S. Hassan, C.L. Ramspek, B. Ferrari, M. van Diepen, R. Rossio, R. Knevel, V. la Mura, A. Artoni, I. Martinelli, A. Bandera, A. Nobili, A. Gori, F. Blasi, C. Canetta, N. Montano, F.R. Rosendaal, F. Peyvandi
Plasma Exchange in a Patient with Immune Thrombocytopenia Associated with Antiphospholipid Syndrome Hospitalized for COVID-19
2022 F. Boggio, A. Ciavarella, S. Arcudi, R. Gualtierotti, R. Rossio, F. Tafuri, A. Artoni, F. Peyvandi
Hemostasis in neonatal ECMO
2022 V. Cortesi, G. Raffaeli, G.S. Amelio, I. Amodeo, S. Gulden, F. Manzoni, G. Cervellini, A. Tomaselli, M. Colombo, G. Araimo, A. Artoni, S. Ghirardello, F. Mosca, G. Cavallaro
Efficacy and safety of azathioprine during remission of immune-mediated thrombotic thrombocytopenic purpura
2022 C. Bichard, I. Mancini, P. Agosti, M. Capecchi, P. De Leo, S. Arcudi, B. Ferrari, S.M. Trisolini, F. Longu, C. Fozza, A. Artoni, F. Peyvandi